Musculoskeletal pain: FDA reporting patterns
52,111 FDA FAERS reports mention Musculoskeletal pain. 32,534 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 8,406 reports
- Adalimumab: 6,325 reports
- Methotrexate: 4,307 reports
- Rituximab: 3,119 reports
- Abatacept: 3,112 reports
- Tocilizumab: 3,027 reports
- Leflunomide: 2,810 reports
- Hydroxychloroquine: 2,699 reports
- Tofacitinib: 2,655 reports
- Infliximab: 2,523 reports
- Sulfasalazine: 2,407 reports
- Secukinumab: 2,258 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.